Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 11
Submit an article Journal homepage
351
Views
10
CrossRef citations to date
0
Altmetric
Psychiatry

Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study

Jeff Scheina Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
,
Ann Childressb Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA
,
Julie Adamsa Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
,
Martin Cloutierc Analysis Group, Inc., Montreal, QC, Canada
,
Patrick Gagnon-Sanschagrinc Analysis Group, Inc., Montreal, QC, CanadaCorrespondence[email protected]
,
Jessica Maitlandc Analysis Group, Inc., Montreal, QC, Canada
,
Rebecca Bungayc Analysis Group, Inc., Montreal, QC, Canada
,
Annie Guérinc Analysis Group, Inc., Montreal, QC, Canada
&
Patrick Lefebvrec Analysis Group, Inc., Montreal, QC, Canada
 show all
Pages 2007-2014 | Received 01 Jul 2021, Accepted 12 Aug 2021, Published online: 27 Aug 2021

References

  • Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395(10222):450–462.
  • Faraone SV, Spencer TJ, Montano CB, et al. Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med. 2004;164(11):1221–1226.
  • Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163(4):716–723.
  • Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304.
  • Ginsberg Y, Quintero J, Anand E, et al. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3). DOI:https://doi.org/10.4088/PCC.13r01600
  • Oliva F, Malandrone F, Mirabella S, et al. Diagnostic delay in ADHD: duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients. Early Interv Psychiatry. 2021;15(4):957–965.
  • Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050–1056.
  • Adler LA, Farahbakhshian S, Romero B, et al. Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder. Postgrad Med. 2019;131(7):461–472.
  • Compton WM, Han B, Blanco C, et al. Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. Am J Psychiatry. 2018;175(8):741–755.
  • Gajria K, Lu M, Sikirica V, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatr Dis Treat. 2014;10:1543–1569. PubMed PMID: 25187718; PubMed Central PMCID: PMCPMC4149449.
  • Stuhec M, Lukic P, Locatelli I. Efficacy, acceptability, and tolerability of lisdexamfetamine, mixed amphetamine salts, methylphenidate, and modafinil in the treatment of attention-deficit hyperactivity disorder in adults: a systematic review and Meta-analysis. Ann Pharmacother. 2019;53(2):121–133.
  • Hodgkins P, Sasane R, Christensen L, et al. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin. 2011;27(sup2):53–62.
  • Olfson M, Marcus SC, Zhang HF, et al. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2007;13(7):570–577.
  • Perwien A, Hall J, Swensen A, et al. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2004;10(2):122–129
  • Kemner JE, Lage MJ. Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis. Ann Gen Psychiatry. 2006;5(1):5. PubMed PMID: 16606463; PubMed Central PMCID: PMCPMC1462992.
  • Asherson P, Buitelaar J, Faraone SV, et al. Adult attention-deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry. 2016;3(6):568–578.
  • Frank E, Ozon C, Nair V, et al. Examining why patients with attention-deficit/hyperactivity disorder lack adherence to medication over the long term: a review and analysis. J Clin Psychiatry. 2015;76(11):e1459–e1468.
  • Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med. 2006;354(14):1445–1448.
  • Adler LA, Childress A, Cloutier M, et al. Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) among adults in the United States: a societal perspective. Value Health. 2021;24(Suppl 1):S128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.